Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Clinical Trial, Phase III"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Zhou%2C+Jianying%22&type=Person&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+III%22
/vufind/Search/Results?lookfor=%22Zhou%2C+Jianying%22&type=Person&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+III%22
Search /vufind/Search2/Results?lookfor=%22Zhou%2C+Jianying%22&type=Person&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+III%22
PubPharm (29)
1
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC
enthalten in:
The New England journal of medicine
| 2023
von
Zhou, C.
|
Solomon, B.
|
Loong, H.
| +122
CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF8. - PMID 37874126
Wird geladen...
2
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer : a multicentre, open-label, randomised phase 3 study
enthalten in:
The Lancet. Respiratory medicine
| 2023
von
Lu, S.
|
Zhou, J.
|
Jian, H.
| +41
CommentIn: Lancet Respir Med. 2023 Oct;11(10):857-859. - PMID 37244264
Wird geladen...
3
Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer : a randomized, multicenter, open-label, phase III trial
enthalten in:
Signal transduction and targeted therapy
| 2023
von
Yang, Y.
|
Min, J.
|
Yang, N.
| +17
Wird geladen...
4
KEYNOTE-033 : Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC
enthalten in:
International journal of cancer
| 2023
von
Ren, S.
|
Feng, J.
|
Ma, S.
| +17
Wird geladen...
5
Interim survival analysis of the randomized phase III GEMSTONE-302 trial : sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
enthalten in:
Nature cancer
| 2023
von
Zhou, C.
|
Wang, Z.
|
Sun, M.
| +31
ErratumIn: Nat Cancer. 2024 Jan 5;:. - PMID 38182915
Wird geladen...
6
Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC : Extended Follow-Up of CameL Phase 3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2023
von
Zhou, C.
|
Chen, G.
|
Huang, Y.
| +54
Wird geladen...
7
Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer : an open-label, randomized controlled phase 3 trial (ORIENT-3)
enthalten in:
Cancer communications (London, England)
| 2022
von
Shi, Y.
|
Wu, L.
|
Yu, X.
| +43
Wird geladen...
8
AENEAS : A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Lu, S.
|
Dong, X.
|
Jian, H.
| +56
CommentIn: J Clin Oncol. 2022 Sep 20;40(27):3103-3105. - PMID 35679530
Wird geladen...
9
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC : a multicenter phase-II trial
enthalten in:
Signal transduction and targeted therapy
| 2021
von
Jiang, T.
|
Wang, P.
|
Zhang, J.
| +22
Wird geladen...
10
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304) : A Randomized Phase 3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2021
von
Lu, S.
|
Wang, J.
|
Yu, Y.
| +19
CommentIn: J Thorac Oncol. 2021 Sep;16(9):1434-1436. - PMID 34425995
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Clinical Trial, Phase III
Medienart
29
Aufsätze
29
E-Artikel
29
E-Ressourcen
Zeitschriftentitel
7
Journal of thoracic oncology : official publica...
4
The Lancet. Respiratory medicine
4
The New England journal of medicine
3
Lung cancer (Amsterdam, Netherlands)
2
Lancet (London, England)
2
Signal transduction and targeted therapy
1
Cancer communications (London, England)
1
International journal of cancer
1
JAMA oncology
1
Journal of clinical oncology : official journal...
1
Nature cancer
1
PloS one
1
The Lancet. Oncology
Alle anzeigen ...
weniger ...
Thema
Clinical Trial, Phase III
29
Journal Article
28
Randomized Controlled Trial
27
Research Support, Non-U.S. Gov't
16
Multicenter Study
12
EC 2.7.10.1
9
Antibodies, Monoclonal, Humanized
7
ErbB Receptors
6
BG3F62OND5
6
Carboplatin
6
Comparative Study
6
EGFR protein, human
6
Protein Kinase Inhibitors
5
04Q9AIZ7NO
5
Pemetrexed
5
Quinazolines
4
53AH36668S
4
9G6U5L461Q
4
Antineoplastic Agents
4
Crizotinib
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
20
2020-
9
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
29
Englisch
Haven't found what you're looking for?
Wird geladen...